These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2460808)

  • 1. Single or repeated administrations of SCH 23390 fail to affect serotonergic neurotransmission.
    Gandolfi O; Roncada P; Dall'Olio R
    Neurosci Lett; 1988 Oct; 92(2):192-6. PubMed ID: 2460808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated trazodone administrations on serotonergic neurotransmission: biochemical studies.
    Gandolfi O; Roncada P; Dall'Olio R
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):941-52. PubMed ID: 2554363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S; Heinrich M; Sonntag JM; Krauss J
    Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum.
    Dewar KM; Lima L; Reader TA
    Neurochem Res; 1990 May; 15(5):507-14. PubMed ID: 2115148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
    Bischoff S; Heinrich M; Krauss J; Sills MA; Williams M; Vassout A
    J Recept Res; 1988; 8(1-4):107-20. PubMed ID: 3290470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists.
    Blackshear MA; Martin LL; Sanders-Bush E
    Neuropharmacology; 1986 Nov; 25(11):1267-71. PubMed ID: 3796800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-H-ketanserin (serotonin type 2) binding in the rat frontal cortex: effect of immobilization stress.
    Torda T; Culman J; Cechová E; Murgas K
    Endocrinol Exp; 1988 Jun; 22(2):99-105. PubMed ID: 3261685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
    Akiyoshi J; Tsuchiyama K; Mizobe Y; Nakamura M; Kuranaga H; Nagayama H
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):165-79. PubMed ID: 7509496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex.
    Okamoto Y; Motohasi N; Hayakawa H; Muraoka M; Yamawaki S
    Neuropsychobiology; 1996; 33(1):17-20. PubMed ID: 8821370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
    Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors.
    Helmeste DM; Tang SW
    Life Sci; 1983 Dec; 33(25):2527-33. PubMed ID: 6139734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
    Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
    Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effect of ketanserin in mice: involvement of supraspinal 5-HT2 receptors in nociceptive transmission.
    Alhaider AA
    Brain Res; 1991 Mar; 543(2):335-40. PubMed ID: 1676334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex.
    Middlemiss DN; Bremer ME; Smith SM
    Eur J Pharmacol; 1988 Nov; 157(1):101-7. PubMed ID: 3234493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex.
    Consolo S; Ramponi S; Ladinsky H; Baldi G
    Brain Res; 1996 Jan; 707(2):320-3. PubMed ID: 8919313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.